Form 13-F position report

ASENSUS SURGICAL INC COM (DE)

Reported by CITADEL ADVISORS LLC

ASXC CUSIP 04367G103 Manager CIK 0001423053

Reported 1,694,459 shares, down 191,141 (10.1%) from the prior quarter.

Reported value -49.3%; share count -10.1% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q1 2022
Shares 1,694,459 Quarter-end amount reported
Reported value $1,062,000 Fair value at quarter end
Consecutive quarters held 5 Through Q1 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 369000
2021-12-31 2093000
2022-03-31 1062000
2022-06-30 184000
2022-09-30 0
2022-12-31 15353
2023-03-31 0
2023-06-30 23447
2023-09-30 0
2023-12-31 16979
2024-03-31 6004
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for ASENSUS SURGICAL INC COM (DE) held by CITADEL ADVISORS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -26,106 (-100.0%) 0 $0 2024-08-14
Q1 2024 Reduced 26,106 -27,137 (-51.0%) < 0.01% $6,004 2024-05-15
Q4 2023 New 53,243 +53,243 (0.0%) < 0.01% $16,979 2024-02-14
Q3 2023 Reduced 0 -46,430 (-100.0%) 0 $0 2023-11-14
Q2 2023 New 46,430 +46,430 (0.0%) < 0.01% $23,447 2023-08-14
Q1 2023 Reduced 0 -44,231 (-100.0%) 0 $0 2023-05-15
Q4 2022 New 44,231 +44,231 (0.0%) < 0.01% $15,353 2023-02-14
Q3 2022 Reduced 0 -461,485 (-100.0%) 0 $0 2022-11-14
Q2 2022 Reduced 461,485 -1,232,974 (-72.8%) < 0.01% $184,000 2022-08-15
Q1 2022 Reduced 1,694,459 -191,141 (-10.1%) < 0.01% $1,062,000 2022-05-16
Q4 2021 Added 1,885,600 +1,686,007 (844.7%) < 0.01% $2,093,000 2022-02-14
Q3 2021 Added 199,593 +173,373 (661.2%) < 0.01% $369,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

130 managers reported ASENSUS SURGICAL INC COM (DE) for Q1 2022.

Managers reporting ASENSUS SURGICAL INC COM (DE) in Q1 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 15,433,427 -360,564 < 0.01% $9,673,000 5 qtrs
VANGUARD GROUP INC Reduced 10,140,049 -1,027,932 < 0.01% $6,356,000 5 qtrs
STATE STREET CORPORATION Reduced 7,025,555 -5,677,718 < 0.01% $4,404,000 5 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 3,724,331 -112,273 < 0.01% $2,334,000 5 qtrs
ADVISOR GROUP HOLDINGS INC Added 278,035 +30,676 < 0.01% $2,088,000 5 qtrs
NORTHERN TRUST CORPORATION Reduced 1,957,474 -114,188 < 0.01% $1,228,000 5 qtrs
MORGAN STANLEY Reduced 1,717,399 -110,841 < 0.01% $1,077,000 5 qtrs
CITADEL ADVISORS LLC This report Reduced 1,694,459 -191,141 < 0.01% $1,062,000 5 qtrs
Rafferty Asset Management LLC Reduced 1,456,254 -250,403 < 0.01% $913,000 4 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 1,388,202 -394,659 < 0.01% $870,000 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2022
Filed
May 16, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,694,459
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.